Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

White House Unveils Actions To Speed Precision Medicine

This article was originally published in Scrip

Executive Summary

The White House on Feb. 25 unveiled new actions and commitments from government agencies, including the National Institutes of Health (NIH) and the FDA, and private-sector participants, including Pfizer Inc. and Roche AG unit Genentech Inc., aimed at speeding President Barack Obama's Precision Medicine Initiative (PMI) forward.


Related Content

'App-A-Thon' Aims To Create PrecisionFDA Software Library To Advance Next-Gen Sequencing